|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02334839 |
|
Date of registration:
|
06/01/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction
|
|
Scientific title:
|
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction |
|
Date of first enrolment:
|
September 2014 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02334839 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Liran Hiersch |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Rabin Medical Center |
|
|
Name:
|
Liran Hiersch |
|
Address:
|
|
|
Telephone:
|
+972-9377490 |
|
Email:
|
liranh@clalit.org.il |
|
Affiliation:
|
|
|
|
Name:
|
Liran Hiersch |
|
Address:
|
|
|
Telephone:
|
+972-3-9377490 |
|
Email:
|
liranh@clalit.org.il |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Maternal age 18-40 years old
2. 27 and above weeks of gestation
3. Singleton pregnancy
4. Agreed to participate in the study and signed on informed consent form.
Exclusion Criteria:
1. Known ischemic heart disease or angina pectoris
2. Active smoker
3. Dyslipidemia, chronic hypertension. Renal disease, diabetes mellitus (gestational or
pregestational)
4. Active treatment with anti-hypertensive medication, anti-aggregation medication or
lipid lowering agents.
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Endothelial Dysfunction
|
|
Intervention(s)
|
|
Other: Observational only
|
|
Primary Outcome(s)
|
|
Reactive Hyperemia Index (RHI)
[Time Frame: 24 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|